- Home
- ARCT vs SIBN Comparison
ARCT vs SIBN Comparison
Compare ARCT & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- SIBN
- Stock Information
- Founded
- ARCT 2013
- SIBN 2008
- Country
- ARCT United States
- SIBN United States
- Employees
- ARCT N/A
- SIBN N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- SIBN Medical/Dental Instruments
- Sector
- ARCT Health Care
- SIBN Health Care
- Exchange
- ARCT Nasdaq
- SIBN Nasdaq
- Market Cap
- ARCT 602.7M
- SIBN 557.9M
- IPO Year
- ARCT N/A
- SIBN 2018
- Fundamental
- Price
- ARCT $16.02
- SIBN $12.92
- Analyst Decision
- ARCT Strong Buy
- SIBN Strong Buy
- Analyst Count
- ARCT 7
- SIBN 7
- Target Price
- ARCT $65.00
- SIBN $23.43
- AVG Volume (30 Days)
- ARCT 400.2K
- SIBN 504.2K
- Earning Date
- ARCT 11-07-2024
- SIBN 11-12-2024
- Dividend Yield
- ARCT N/A
- SIBN N/A
- EPS Growth
- ARCT N/A
- SIBN N/A
- EPS
- ARCT N/A
- SIBN N/A
- Revenue
- ARCT $160,399,000.00
- SIBN $157,035,000.00
- Revenue This Year
- ARCT $13.02
- SIBN $21.87
- Revenue Next Year
- ARCT $5.58
- SIBN $17.34
- P/E Ratio
- ARCT N/A
- SIBN N/A
- Revenue Growth
- ARCT N/A
- SIBN 18.98
- 52 Week Low
- ARCT $14.93
- SIBN $11.76
- 52 Week High
- ARCT $45.00
- SIBN $21.70
- Technical
- Relative Strength Index (RSI)
- ARCT 31.24
- SIBN 43.41
- Support Level
- ARCT $18.90
- SIBN $12.24
- Resistance Level
- ARCT $21.61
- SIBN $16.18
- Average True Range (ATR)
- ARCT 1.15
- SIBN 0.88
- MACD
- ARCT -0.07
- SIBN -0.11
- Stochastic Oscillator
- ARCT 16.32
- SIBN 18.09
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.